Quick-Med's Novel Wound Dressing Receives Recognition from the Wound Healing Society

Quick-Med Technologies, Inc. (OTCBB:QMDT) is pleased to announce that the Wound Healing Society has recognized the innovative work of a team of its scientists with the Society’s prestigious Blue Ribbon Award. The award, which was presented at the recent Symposium on Advanced Wound Care and Wound Healing Society’s 21st Annual Meeting, recognized the outstanding abstract entitled: "Absorbent Microbicidal Wound Dressing Material with Protease Inhibition Properties.” The abstract was sponsored by Quick-Med Technologies and the University of Florida at Gainesville. The Wound Healing Society offers the Blue Ribbon Industrial Research & Development Award to recognize the best product-oriented research performed by research and development scientists within the corporate world. This year, a total of 11 blue ribbons were awarded including 2 to teams from Quick-Med Technologies. Other participants at the SAWC/WHS event were prominent companies such as Johnson & Johnson Wound Management, 3M Healthcare, Kinetic Concepts, Inc., and Healthpoint, Ltd., as well as leading educational institutions such as the Harvard Medical School, Stanford University, and the University of Pennsylvania School of Medicine. "This marks the third blue ribbon received by the QMT Research Center in the past three years, and it represents recognition by our peers of the quality of work done by our research team,” said Dr. Gerald Olderman, Vice President of Research & Development for Quick-Med Technologies. "This work will ultimately form the basis of the development of unique wound dressing products that are targeted at reduced risk of infections and speedier healing.” The project team is lead by Bernd Liesenfeld1 and includes Gregory Schultz1,2, John Aseke2, Olajompo Moloye2, William Toreki1, Roy Carr1, David Moore1, and Gerald Olderman1. (1Quick-Med Technologies; Inc.; 2University of Florida) Experimental results demonstrate the capacity of a NIMBUS® wound dressing to not only deliver the strong antimicrobial efficacy but also to preferentially ionically bind proteases and sequester them within the wound dressing. This strategy permits the control of microbes and the suppression of protease activity without leaching any material into the wound bed, thus eliminating the associated interference with the wound-healing process. The poster in its entirety can be accessed at http://www.quickmedtech.com/technology-platforms/technology-nimbus.php About the Wound Healing Society The Wound Healing Society is a non-profit organization composed of clinical and basic scientists. The Society provides a forum for interaction among scientists, physicians, licensed practitioners, industrial representatives and government agencies. Founded in 1990, the Society is recognized among professionals and government agencies as the leading scientific organization focused in this area of wound healing. The Society publishes the leading journal in this area, Wound Repair and Regeneration. About Quick-Med Technologies, Inc. Quick-Med Technologies, Inc. is a life sciences company that is developing innovative technologies for the healthcare and consumer markets. For more information, see: www.quickmedtech.com. © 2008 Quick-Med Technologies, Inc. All rights reserved. NIMBUS® is a registered trademark of Quick-Med Technologies, Inc. Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may", "will", "to", "expect", "plan", "believe", "anticipate", "intend", "could", "would", "estimate", and/or "continue" or the negative or other variations thereof or comparable terminology is intended to identify forward-looking statements involve risks and uncertainties, including those risks that are discussed in the Company's filings with the Securities and Exchange Commission ("SEC"), which may be accessed at the SEC's Edgar System at www.sec.gov.